Demser (Aton Pharma, Inc.)


Welcome to the PulseAid listing for the Demser drug offered from Aton Pharma, Inc.. This Catecholamine Synthesis Inhibitor [EPC],Catecholamine Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aton Pharma, Inc.
NON-PROPRIETARY NAME: metyrosine
SUBSTANCE NAME: METYROSINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Catecholamine Synthesis Inhibitor [EPC],Catecholamine Synthesis Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1979-10-03
END MARKETING DATE: 0000-00-00


Demser HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDemser from Aton Pharma, Inc.
LABELER NAME: Aton Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1979-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25010-305_00baa448-ed18-4e30-80f5-77b5695e98b7
PRODUCT NDC: 25010-305
APPLICATION NUMBER: NDA017871

Other METYROSINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aton Pharma, Inc.Demser